These finding highlights that even a modest 30% inhibition of Rac activity, observed at HV-107 concentrations of 100–250 nM, can exert a substantial influence on the remodeling of the extracellular matrix and the invasive capacity of breast cancer cells. Here, AKT1 is linked to breast carcinoma.